甘露聚糖肽联合氯雷他定治疗慢性荨麻疹的分析

Analysis of mannan peptide combined with loratadine in the treatment of chronic urticaria

目的:探究应用甘露聚糖肽联合氯雷他定治疗慢性荨麻疹的临床治疗效果。方法:选取接受慢性荨麻疹治疗的患者80例,将其随机分为对照组和试验组,平均每组40例,对照组氯雷他定治疗,试验组甘露聚糖肽联合氯雷他定治疗,观察、比较两组患者的临床治疗效果。结果:试验组治疗后的总有效率(90%)明显高于对照组治疗后的总有效率(60%),两组有显著性差异,有统计学意义(P<0.05)。结论:甘露聚糖肽联合氯雷他定治疗慢性荨麻疹中,安全并且见效速度快、能达到很好的痊愈效果,值得临床应用推广。

Objective To explore the clinical therapeutic effect of application of mannan peptide combined with loratadine in the treatment of chronic urticaria. Method 80 patients who received the treatment of chronic urticaria nearly two years were randomly divided into the con-trol group and the experimental group,with 40 people in each group,the control group received loratadine for treatment,the experimental group received Mannan peptide combined with loratadine for treatment,the clinical therapeutic effect of two groups was observed and com-pared. Results The total efficiency of the experimental group after the treatment（ 90%） was significantly higher than the control group （60%）,there was significant difference between two groups,with statistical significance（P﹤0. 05）. Conclusion Mannan peptide combined with loratadine in the treatment of chronic urticaria,which can achieve good cure effect,it is worthy of clinical application because its safety and quick reply.